Venous thromboembolism
-
SupplementInitiation, extension, prevention—A focus on the role of Xarelto®▼ (rivaroxaban) in management of venous thromboembolism
Information intended for healthcare professionals only. This supplement has been developed in partnership with Bayer plc. Please see bottom of the page for full disclaimer. View prescribing information Download a PDF of the supplement Experience with pre-labelled initiation ...
-
Test and reflect
Best practice in venous thromboembolism
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on venous thromboembolism in primary care—you will then be prompted to reflect on your learning.
-
Implementing guidelines
NICE VTE pathway is blueprint for reducing death and disability
Dr Anil Kamat shows how the NICE interactive pathway on VTE distils current guidance and support for the diagnosis, treatment, and management of this preventable condition
-
NICE quality standard article
NICE quality standard brings management of VTE system-wide
Drs Alex Coupland and Gavin Flatt and Professor Gerard Stansby show how using the quality standard will improve the diagnosis and management of VTE
-
Implementing guidelines
The two-level Wells scores should be used in suspected VTE cases
Adriano Sala Tenna, Scott Harrison, Liz Avital, and Gerard Stansby discuss how the NICE guideline aims to improve identification and management of DVT and PE
-
Implementing guidelines
All patients admitted to hospital should be assessed for VTE risk
Dr Henry Watson discusses how the SIGN recommendations will help to improve identification of patients with venous thromboembolism and provision of prophylactic treatment
-
Implementing guidelines
All patients admitted to hospital should be assessed for risk of VTE
Professor Tom Treasure (left), Dr Lee-Yee Chong, and Dr Jennifer Hill outlinethe NICE guideline on the prevention of venous thromboembolism and the use of prophylaxis
-
Personal view
VTE prophylaxis: new drug option recommended by NICE
NICE TA170 recommends the use of rivaroxaban after total elective hip or knee surgery, says Professor Sam Machin
-
Implementing guidelines
Extended treatment is needed to prevent VTE in post-surgical patients
Professor Samuel Machin discusses the implications for primary care of NICE recommendations on long-term prophylaxis for venous thromboembolism after hip surgery
-
Personal view
Guideline aims to reduce venous thromboembolism
New SIGN guidance will help GPs identify patients at increased risk of DVT and pulmonary embolism, says Dr Peter Saul
